Skip to content
HeyJared

Joanne S. Hawana

Reporter · US

Indexed articles, last 90 days
3
Latest publication
Sep 18, 2026
Outlet visibility, for Mondaq
Top 500K sites
Earliest in this view
Jul 30, 2026

Latest articles

  1. Article · Sep 18, 2026 · Joanne S. Hawana

    FDA In Flux — September 2026 Newsletter (opens the original)

    Excerpt · English

    Read excerpt

    Welcome to FDA in Flux — A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and consumer product investment decisions and development strategies. What is happening: In August, FDA’s Center for Devices and Radiological Health (CDRH), through its Digital Health Center of Excellence, published a discussion paper titled “Considerations for the Regulation of Generative AI-Enabled Medical Devices.” The paper seeks early input from stakeholders on

  2. Article · Aug 14, 2026 · Joanne S. Hawana

    FDA In Flux — August 2026 Newsletter (opens the original)

    Excerpt · English

    Read excerpt

    Welcome to FDA in Flux — A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and consumer product investment decisions and development strategies. What is happening: Earlier this summer, the Department of Health and Human Services (HHS) released “Operation TrialBlazer,” a sweeping roadmap designed to accelerate US-based clinical research and reverse what the Trump administration characterizes as a growing competitive threat from abroad (“the

  3. Article · Jul 30, 2026 · Joanne S. Hawana

    FDA’s Advisory Committee Votes On Peptides: What It Does And Doesn’t Do (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    A hastily reassembled Pharmacy Compounding Advisory Committee (PCAC) held meetings on July 23 and 24, 2026 to consider whether seven unapproved peptides should be included on an affirmative list of bulk ingredients that can be used by compounding pharmacies operating under the Food, Drug, & Cosmetic Act’s (FD&C Act) Section 503A (503A compounders). A second PCAC meeting to discuss an additional five peptides is expected to be scheduled in February 2027. In close votes over the course of July’s t

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 500K sites

For Mondaq, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Joanne S. Hawana